# Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

> **NCT02232802** · PHASE1 · COMPLETED · sponsor: **Chemi S.p.A.** · enrollment: 47 (actual)

## Conditions studied

- Enoxaparin Sodium is Administered to Healthy Volunteers

## Interventions

- **DRUG:** Enoxaparin Sodium
- **DRUG:** Enoxaparin Sodium

## Key facts

- **NCT ID:** NCT02232802
- **Lead sponsor:** Chemi S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-04
- **Primary completion:** 2014-12-05
- **Final completion:** 2014-12-05
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02232802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02232802, "Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02232802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*